Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose–volume constraints with long-term endocrine outcomes. (December 2022)

• Record Type: Journal Article
• Authors: Chow, James C.H.; Lui, Jeffrey C.F.; Cheung, Ka-Man; Tam, Anthony H.P.; Lam, Martin H.C.; Yuen, Tony Y.S.; Lee, Francis K.H.; Leung, Alex K.C.; Au, Kwok-Hung; Ng, Wai-Tong; Lee, Anne W.M.; Kwan, Chung-Kong; Yiu, Harry H.Y.
• Is Part Of: Radiotherapy and oncology. Volume 177(2022)
• Page Start: 105
• Page End: 110
• Publication Date: 2022-12
• Subjects: Hypothyroidism -- Nasopharyngeal carcinoma -- Intensity-modulated radiotherapy -- Radiation dosimetry -- Survivorship; Oncology -- Periodicals; Radiotherapy -- Periodicals; Tumors -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- radiotherapy -- Periodicals; Radiotherapy -- Periodicals; Radiothérapie -- Périodiques; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9940642
• DOI: 10.1016/j.radonc.2022.10.034
• Languages: English
• ISSNs: 0167-8140

Abstract

Highlights: We externally validated 22 dose-volume constraints of the thyroid gland using long-term endocrine outcomes of 488 HNC patients. Over a median follow-up period of 6.8 years, 42.0 % of patients developed post-radiation primary hypothyroidism. Thyroid VS60 had the largest area under time-dependent ROC curve of 0.698 at 5 years after radiotherapy. Thyroid VS60 at a cutoff value of 10 cc had the highest F-score of 0.53. The 5-year hypothyroidism risks of patients with thyroid VS60 ≥ 10 cc and < 10 cc were 14.7 % and 38.2 %, respectively. Abstract: Background: Post-radiation primary hypothyroidism is a common late complication in head and neck cancer (HNC) survivors. No radiation dose-volume constraint of the thyroid gland has been externally validated for predicting long-term thyroid function outcomes. Materials and Methods: This external validation study evaluated the diagnostic properties of 22 radiation dose–volume constraints of the thyroid gland proposed in the literature. Radiation dosimetric data from 488 HNC patients who underwent neck irradiation from January 2013 to December 2015 at two tertiary oncology centers were reviewed. The diagnostic metrics of candidate constraints were computed by inverse probability of censoring weighting and compared using time-dependent receiver operating characteristic (ROC) curves with death designated as a competing event. Multivariable regression analyses were performed using the Fine–Gray sub-distribution hazard model. Results: Over a median follow-up period of 6.8 years, 205 (42.0 %) patients developed post-radiation primary hypothyroidism. The thyroid volume spared from 60 Gy (VS60) had the largest area under ROC curve of 0.698 at 5 years after radiotherapy. Of all evaluated constraints, VS60 at a cutoff value of 10 cc had the highest F-score of 0.53. The 5-year hypothyroidism risks of patients with thyroid VS60 ≥ 10 cc and < 10 cc were 14.7 % and 38.2 %, respectively ( p < 0.001). The adjusted sub-hazard ratio for post-radiation primary hypothyroidism for VS60 < 10 cc was 1.87 (95 % confidence interval, 1.22–2.87; p < 0.001). Conclusion: Thyroid VS60 is the best radiation dose–volume parameter to predict the long-term risk of primary hypothyroidism in patients with HNC who underwent neck irradiation. VS60 ≥ 10 cc is a robust constraint that limits the 5-year primary hypothyroidism risk to less than 15 % and should be routinely employed during radiotherapy optimization.